381MO Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)

D.S. Hong, Y-J. Bang, F. Barlesi, G. Durm, G.S. Falchook,R. Govindan,G.K. Dy, K. Park, J.H. Strickler,T.F. Burns,J. Kim,A. Ang, J.R. Lipford, G. Ngarmchamnanrith,A. Anderson,B.T. Li

Annals of Oncology(2020)

引用 2|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要